Gaithersburg, MD, United States of America

Vivek Shinde

This inventor holds 1 USPTO granted patent and 1 published patent application. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vivek Shinde. Retrieved from https://idiyas.com/inventor/vivek-shinde

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vivek Shinde: Inventor of a Combined Coronavirus and Influenza Vaccine Approach

Introduction

Vivek Shinde is an inventor based in Gaithersburg, Maryland. His patent work addresses vaccine compositions designed to induce immune responses against both influenza viruses and coronaviruses.

Latest Patents

Shinde is associated with one patent, titled “Coronavirus and influenza compositions and methods for using them.” The disclosed compositions combine a coronavirus S glycoprotein presented in a detergent-core nanoparticle using a non-ionic detergent, at least three hemagglutinin glycoproteins from different influenza strains, and a pharmaceutically acceptable buffer. The patent describes methods for using these compositions to induce immune responses against both groups of viruses.

Career Highlights

A key highlight of Shinde’s patent record is this combined approach to coronavirus and influenza immunization. The invention brings together coronavirus and influenza antigens in a single composition, with the aim of addressing immune responses to multiple viral targets.

Collaborations

Shinde’s listed coworkers include Nita Patel and Mimi Guebre-xabier. Their names are associated with the collaborative context of the patent work described here.

Conclusion

Vivek Shinde’s patent activity centers on a vaccine composition that combines coronavirus and influenza components, reflecting an effort to support immune responses against both types of viruses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…